NASDAQ:INDV | Income Statement | Indivior Pharmaceuticals, Inc.

Complete source-backed income-statement history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$343M$50M$294M$122M$134M$160M$160M$38M$122M$1.02$0.98119,000,000124,000,000
2026-03-31$317M$40M$277M$124M$139M$137M$115M$26M$89M$0.71$0.69124,000,000129,000,000
2025-12-31$358M$67M$292M$189M$81M$81M-$21M$102M$0.81$0.7901,000,000
2025-09-30$314M$83M$230M$155M$187M$43M$37M-$5M$42M$0.34$0.33125,000,000129,000,000
2025-06-30$302M$52M$250M$158M$179M$72M$62M$44M$18M$0.15$0.14125,000,000126,000,000
2025-03-31$266M$44M$221M$133M$156M$66M$59M$11M$47M$0.38$0.38124,000,000125,000,000
2024-12-31$299M$48M$250M$175M$204M$46M$38M$17M$21M$0.16$0.16-2,000,000-1,000,000
2024-09-30$307M$66M$241M$142M$206M$35M$30M$8M$22M$0.16$0.16132,000,000133,000,000
2024-06-30$299M$79M$220M$152M$338M-$118M-$121M-$23M-$97M-$0.72-$0.72135,000,000135,000,000
2024-03-31$284M$38M$246M$143M$171M$75M$73M$11M$61M$0.45$0.45136,000,000137,000,000

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$1.24B$246M$994M$634M$262M$239M$29M$210M$1.68$1.64125,000,000128,000,000
2024-12-31$1.19B$231M$957M$612M$919M$38M$20M$13M$7M$0.05$0.05132,000,000133,000,000
2023-12-31$1.09B$174M$919M$565M$1.07B-$152M-$145M-$19M-$126M-$0.92-$0.92137,000,000137,000,000
2022-12-31$901M$151M$749M$469M$831M-$81M-$89M-$44M-$44M-$0.32-$0.32139,000,000139,000,000